These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16574354)

  • 21. Nanostructured lipid carriers as novel carrier for sunscreen formulations.
    Xia Q; Saupe A; Müller RH; Souto EB
    Int J Cosmet Sci; 2007 Dec; 29(6):473-82. PubMed ID: 18489386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
    Schubert MA; Harms M; Müller-Goymann CC
    Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
    Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
    J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
    Silva AC; Santos D; Ferreira DC; Souto EB
    Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
    Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
    Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate.
    Feng F; Zheng D; Zhang D; Duan C; Wang Y; Jia L; Wang F; Liu Y; Gao Q; Zhang Q
    J Microencapsul; 2011; 28(4):280-5. PubMed ID: 21545318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
    Uner M
    Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of lycopene-loaded nanostructured lipid carriers: effect of rice oil and cholesterol.
    Riangjanapatee P; Müller RH; Keck CM; Okonogi S
    Pharmazie; 2013 Sep; 68(9):723-31. PubMed ID: 24147340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.